Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.8250-0.3550 (-8.49%)
At close: 03:46PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/3/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.05
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 310.4200
52 Week Low 32.3200
50-Day Moving Average 33.8282
200-Day Moving Average 34.8386

Share Statistics

Avg Vol (3 month) 32.09k
Avg Vol (10 day) 3830
Shares Outstanding 534.81M
Implied Shares Outstanding 6N/A
Float 827.71M
% Held by Insiders 10.00%
% Held by Institutions 19.97%
Shares Short (Oct 13, 2022) 45.73k
Short Ratio (Oct 13, 2022) 42.25
Short % of Float (Oct 13, 2022) 4N/A
Short % of Shares Outstanding (Oct 13, 2022) 40.02%
Shares Short (prior month Sep 14, 2022) 49.08k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,795.86%

Management Effectiveness

Return on Assets (ttm)-29.16%
Return on Equity (ttm)-198.69%

Income Statement

Revenue (ttm)2.66M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)0.80%
Gross Profit (ttm)2.65M
EBITDA -47.6M
Net Income Avi to Common (ttm)-43M
Diluted EPS (ttm)-1.6190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)63.02M
Total Cash Per Share (mrq)1.81
Total Debt (mrq)45.11M
Total Debt/Equity (mrq)2,517.08
Current Ratio (mrq)1.71
Book Value Per Share (mrq)1.19

Cash Flow Statement

Operating Cash Flow (ttm)-32.32M
Levered Free Cash Flow (ttm)-19.73M
Advertisement
Advertisement